Qureight
Latest round
- Series B
Last raised
- Mar 2026
Total raised
- $31M
Investors
- 9
About Qureight
, operates as a clinical data analytics company working with healthcare institutions, technology companies, and the pharmaceutical industry that allows the realisation of new endpoints in clinical data. In July 2026, Qureight Ltd. The company offers a digital platform that allows healthcare companies to manage, curate, and post-process clinical data centrally. The company’s platform integrates with various existing artificial intelligence-based software systems, helping users upload imaging and biomarker data, transform clinical information into structured task-ready data, and process complex data with proprietary tools.
Who invested in Qureight
9 investors across 3 rounds
See all investors in Qureight
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Qureight
Who invested in Qureight?
Qureight has 9 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Qureight raised?
Qureight has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Qureight last raise money?
Qureight's most recent round on record is a Series B, in Mar 2026.
What does Qureight do?
, operates as a clinical data analytics company working with healthcare institutions, technology companies, and the pharmaceutical industry that allows the realisation of new endpoints in clinical data.
Where is Qureight headquartered?
Qureight is headquartered in Cambridge, UK.
Which VCs invest in companies like Qureight?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back healthcare it companies at Qureight's stage. Their profiles are linked below.
VCs backing healthcare it startups at Series B
Raising like Qureight? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.